Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS - Moreau, Philippe; Chari, Ajai; Oriol, Albert; Martinez-Lopez, Joaquin; Haenel, Mathias; Touzeau, Cyrille; Ailawadhi, Sikander; Besemer, Britta; de la Rubia Comos, Javier; Encinas, Cristina; Mateos, Maria-Victoria; Salwender, Hans; et al. (Blood cancer journal, 2023)
Gesehen am 27.11.2023